Genetics of Pancreatic Neuroendocrine Tumors

Chirayu Mohindroo1, Florencia McAllister2, Ana De Jesus-Acosta3

  • 1Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1360, Houston, TX 77030, USA; Department of Internal Medicine, Sinai Hospital of Baltimore, 2435 W. Belvedere Ave, Ste 56, Baltimore, MD 21215, USA.

Insights

Pancreatic neuroendocrine tumors (pNETs) are increasingly diagnosed. Genetic analysis reveals key mutations like MEN1 and DAXX/ATRX in sporadic pNETs, and links inherited forms to specific syndromes.

Area of Science:

  • Oncology
  • Genetics
  • Endocrinology

Background:

  • Pancreatic neuroendocrine tumors (pNETs) incidence is rising.
  • Next-generation sequencing advances pNETs genetic understanding.

Purpose of the Study:

  • To review and update current knowledge on pNETs genetics.
  • To highlight driver mutations in sporadic and inherited pNETs.

Main Methods:

  • Literature review of genetic studies in pNETs.
  • Analysis of next-generation sequencing data.

Main Results:

  • Sporadic pNETs commonly show MEN1, DAXX/ATRX, and mTOR pathway gene mutations.
  • Inherited pNETs are associated with MEN1, VHL, NF1, and TSC.

Conclusions:

  • Genetic landscape of pNETs is complex and evolving.
  • Understanding pNETs genetics is crucial for diagnosis and treatment.

Related Concept Videos